Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 19;19(3):1078.
doi: 10.3390/ijerph19031078.

Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study

Siti Norain Azahar  1 , Saperi Sulong  2 , Wan Asyraf Wan Zaidi  3 , Norliza Muhammad  1 , Yusof Kamisah  1 , Norliana Masbah  1
Affiliations

Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study

Siti Norain Azahar et al. Int J Environ Res Public Health. .

Abstract

Background: Stroke has significant direct medical costs, and direct oral anticoagulants (DOACs) are better alternatives to warfarin for stroke prevention in atrial fibrillation (AF). This study aimed to determine the direct medical costs of stroke, with emphasis on AF stroke and the cost-effectiveness of DOACs among stroke patients in a tertiary hospital in Malaysia.

Methods: This study utilised in-patient data from the case mix unit of Universiti Kebangsaan Malaysia Medical Centre (UKMMC) between 2011 and 2018. Direct medical costs of stroke were determined using a top-down costing approach and factors associated with costs were identified. Incremental cost effectiveness ratio (ICER) was calculated to compare the cost-effectiveness between DOACs and warfarin.

Results: The direct medical cost of stroke was MYR 11,669,414.83 (n = 3689). AF-related stroke cases had higher median cost of MYR 2839.73 (IQR 2269.79-3101.52). Regression analysis showed that stroke type (AF versus non-AF stroke) (p = 0.013), stroke severity (p = 0.010) and discharge status (p < 0.001) significantly influenced stroke costs. DOACs were cost-effective compared to warfarin with an ICER of MYR 19.25.

Conclusions: The direct medical cost of stroke is substantial, with AF-stroke having a higher median cost per stroke care. DOACs were cost effective in the treatment of AF-related stroke in UKMMC.

Keywords: atrial fibrillation; cost-effectiveness analysis; direct medical cost; direct oral anticoagulants; stroke.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Abbott A.L., Silvestrini M., Topakian R., Golledge J., Brunser A.M., De Borst G.J., Harbaugh R.E., Doubal F.N., Rundek T., Thapar A., et al. Optimizing the Definitions of Stroke, Transient Ischemic Attack, and Infarction for Research and Application in Clinical Practice. Front. Neurol. 2017;8:537. doi: 10.3389/fneur.2017.00537. - DOI - PMC - PubMed
    1. Johnson C.O., Nguyen M., Roth G.A., Nichols E., Alam T., Abate D., Abd-Allah F., Abdelalim A., Abraha H.N., Abu-Rmeileh N.M., et al. Global, regional, and national burden of stroke, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:439–458. doi: 10.1016/S1474-4422(19)30034-1. - DOI - PMC - PubMed
    1. Alkhouli M., Alqahtani F., Aljohani S., Alvi M., Holmes D.R. Burden of Atrial Fibrillation–Associated Ischemic Stroke in the United States. JACC: Clin. Electrophysiol. 2018;4:618–625. doi: 10.1016/j.jacep.2018.02.021. - DOI - PubMed
    1. Benjamin E.J., Virani S.S., Callaway C.W., Chamberlain A.M., Chang A.R., Cheng S., Chiuve S.E., Cushman M., Delling F.N., Deo R., et al. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association. Circulation. 2018;137:e67–e492. doi: 10.1161/CIR.0000000000000558. - DOI - PubMed
    1. Wang K.-L., Lip G.Y.H., Chiang C.-E. Stroke prevention in atrial fibrillation: An Asian perspective. Thromb. Haemost. 2014;111:789–797. doi: 10.1160/TH13-11-0948. - DOI - PubMed

Publication types